TUESDAY, Jan. 25, 2022 (HealthDay News) — Pfizer Inc. announced Tuesday that it has launched a trial that will compare its existing COVID-19 vaccine against a new version tailored to beat back the highly contagious Omicron variant. “While current research and real-world data show that boosters continue to provide aContinue Reading

MONDAY, Jan. 24, 2022 (healthDay News) — The U.S. Food and Drug Administration said Monday that it will curtail the use of two monoclonal antibody treatments that do not appear to work against the highly contagious Omicron variant. The combo treatments bamlanivimab/etesevimab and casirivimab/imdevimab, made by Eli Lilly and Regeneron,Continue Reading

MONDAY, Jan. 24, 2022 (HealthDay News) — Coronavirus testing requirements for vaccinated people arriving in England will be scrapped, British Prime Minister Boris Johnson announced Monday. Details about the changes are to be provided later in the day by Transport Secretary Grant Shapps, the Associated Press reported. To “show thatContinue Reading

MONDAY, Jan. 24, 2022 (HealthDay News) — While it appears that Black Americans were more hesitant than white Americans to roll up their sleeves when the COVID-19 vaccines launched last year, that unwillingness has lessened. Following 1,200 U.S. adults through much of the pandemic, researchers found Black people were moreContinue Reading

MONDAY, Jan. 24, 2022 (healthDay News) — The U.S. Food and Drug Administration may soon curtail the use of two monoclonal antibody treatments that do not appear to work against the highly contagious Omicron variant. The treatments made by Regeneron and Eli Lilly performed well against earlier variants, but onlyContinue Reading

MONDAY, Jan. 24, 2022 (HealthDay News) — When American kids do downhill skiing or snowboarding, they almost always wear a helmet, their parents say, but they’re far less likely to do so when cruising down a neighborhood hill on a sled. That puts them at risk for serious head injuries,Continue Reading

FRIDAY, Jan. 21, 2022 (HealthDay News) — Herd immunity against COVID-19 is unlikely, and coping with the disease will likely hinge on vaccination, treatment and ensuring adequate hospital capacity, a new study conducted in Los Angeles County claims. With herd immunity, most people have antibodies from vaccination or prior infection,Continue Reading